Quantitative multiparametric MRI allows safe surgical planning in patients undergoing liver resection for colorectal liver metastases: report of two patients.


Journal

BJR case reports
ISSN: 2055-7159
Titre abrégé: BJR Case Rep
Pays: England
ID NLM: 101684132

Informations de publication

Date de publication:
01 May 2021
Historique:
received: 03 10 2020
revised: 16 12 2020
accepted: 26 12 2020
entrez: 16 6 2021
pubmed: 17 6 2021
medline: 17 6 2021
Statut: epublish

Résumé

It is not uncommon for clinicians to encounter varying degrees of hepatic steatosis in patients undergoing resection for colorectal liver metastases (CRLM). Magnetic resonance imaging is currently the preferred investigation for identification and pre-operative planning of these patients. An objective assessment of liver quality and degree of steatosis is paramount for planning a safe resection, which is seldom provided by routine MRI sequences. We studied two patients who underwent an additional pre-operative multiparametric MRI scan (LiverMultiScan

Identifiants

pubmed: 34131498
doi: 10.1259/bjrcr.20200172
pmc: PMC8171142
doi:

Types de publication

Case Reports

Langues

eng

Pagination

20200172

Informations de copyright

© 2021 The Authors. Published by the British Institute of Radiology.

Déclaration de conflit d'intérêts

Conflicts of interest: JJC, EP and MK are employees and shareholders at Perspectum Ltd. TJK undertakes consultancy work for Perspectum Ltd on an unrelated project. There are no other actual or perceived conflicts of interest to declare.

Références

PLoS One. 2020 Dec 2;15(12):e0238568
pubmed: 33264327
Ann Surg Oncol. 2011 Feb;18(2):421-30
pubmed: 20844968
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Int J Surg. 2018 Apr;52:74-81
pubmed: 29425829
J Pathol Inform. 2013 Dec 31;4:36
pubmed: 24524002
HPB (Oxford). 2010 May;12(4):277-84
pubmed: 20590898
BMC Cancer. 2018 Sep 12;18(1):890
pubmed: 30208871
NMR Biomed. 2015 Jun;28(6):706-14
pubmed: 25908098
Br J Surg. 2011 Sep;98(9):1309-17
pubmed: 21598236
Br J Radiol. 2018 Sep;91(1089):20170959
pubmed: 29722568
Lancet. 2008 Mar 22;371(9617):1007-16
pubmed: 18358928
Cir Esp. 2010 Dec;88(6):404-12
pubmed: 20971458
Sci Rep. 2018 Jun 15;8(1):9189
pubmed: 29907829
Ann Surg Oncol. 2012 Dec;19(13):4287-99
pubmed: 22766981
PLoS One. 2018 Sep 20;13(9):e0204175
pubmed: 30235288
J Hepatol. 2016 Feb;64(2):308-315
pubmed: 26471505
Br J Surg. 2007 Mar;94(3):274-86
pubmed: 17315288
Abdom Radiol (NY). 2019 Jan;44(1):72-84
pubmed: 30032383
Surgery. 2011 May;149(5):713-24
pubmed: 21236455
J Hepatol. 2014 Jan;60(1):69-77
pubmed: 24036007

Auteurs

Pulkit Sethi (P)

Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Hospital, Basingstoke, Hampshire, United Kingdom.

Navamayooran Thavanesan (N)

Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Hospital, Basingstoke, Hampshire, United Kingdom.

Fenella Ks Welsh (FK)

Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Hospital, Basingstoke, Hampshire, United Kingdom.

John Connell (J)

Perspectum, Gemini One, Oxford, United Kingdom.

Matt Kelly (M)

Perspectum, Gemini One, Oxford, United Kingdom.

Jonathan A Fallowfield (JA)

Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Timothy J Kendall (TJ)

Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Myrddin Rees (M)

Department of Hepatobiliary Surgery, Basingstoke and North Hampshire Hospital, Basingstoke, Hampshire, United Kingdom.

Classifications MeSH